GMAT Question of the Day: Daily via email | Daily via Instagram New to GMAT Club? Watch this Video

It is currently 31 Mar 2020, 00:23

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

Two alternative drugs are available to prevent blood clots from develo

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Find Similar Topics 
Math Expert
User avatar
V
Joined: 02 Sep 2009
Posts: 62357
Two alternative drugs are available to prevent blood clots from develo  [#permalink]

Show Tags

New post 18 Feb 2020, 03:48
00:00
A
B
C
D
E

Difficulty:

  45% (medium)

Question Stats:

67% (02:16) correct 33% (02:07) wrong based on 82 sessions

HideShow timer Statistics

Two alternative drugs are available to prevent blood clots from developing after a heart attack. According to two major studies, drug Y does this no more effectively than the more expensive drug Z, but drug Z is either no more or only slightly more effective than drug Y. Drug Z’s manufacturer, which has engaged in questionable marketing practices such as offering stock options to doctors who participate in clinical trials of drug Z, does not contest the results of the studies but claims that they do not reveal drug Z’s advantages. However, since drug Z does not clearly treat the problem more effectively than drug Y, there is no established medical reason for doctors to use drug Z rather than drug Y on their heart-attack victims.

A major flaw in the argument is that the argument


(A) does not consider drugs or treatments other than drug Y and Z that may be used to prevent blood clotting in heart-attack patients

(B) neglects to compare the marketing practices of drug Y’s manufacturer with those of drug Z’s manufacturer

(C) fails to recognize that there may be medical criteria relevant to the choice between the two drugs other than their effectiveness as a treatment

(D) assumes without proof that the two drugs are similar in their effectiveness as treatments because they are similar in their chemical composition

(E) confuses economic reasons for selecting a treatment with medical reasons

_________________
Manager
Manager
avatar
S
Joined: 23 Feb 2012
Posts: 83
Location: India
Concentration: Strategy, Technology
Premium Member Reviews Badge
Re: Two alternative drugs are available to prevent blood clots from develo  [#permalink]

Show Tags

New post 22 Mar 2020, 18:30
background: Z is more expensive but slightly more effective than Y.And Z's Manufacturer said Z has other advantages,not revealed by studies yet;
Main Premise :since(premise Indicator keyword) drug Z does not clearly treat the problem more effectively than drug Y;
Conclusion : there is no established medical reason for doctors to use drug Z rather than drug Y on their heart-attack victims.
Prethink: Effectiveness is the only criteria? There cud be other medical criteria,drugs' side-effects?
A major flaw in the argument is that the argument : POE
(A) does not consider drugs or treatments other than drug Y and Z that may be used to prevent blood clotting in heart-attack patients. Comparison is between Y & Z. So other drug is out of scope any way.
(B) neglects to compare the marketing practices of drug Y’s manufacturer with those of drug Z’s manufacturer. :not a medical Reason;
(C) fails to recognize that there may be medical criteria relevant to the choice between the two drugs other than their effectiveness as a treatment : Correct
(D) assumes without proof that the two drugs are similar in their effectiveness as treatments because they are similar in their chemical composition: Chemical composition is not given Oout of Scope
(E) confuses economic reasons for selecting a treatment with medical reasons; Economic reasons are not in main Premise, but effectiveness .
GMAT Club Bot
Re: Two alternative drugs are available to prevent blood clots from develo   [#permalink] 22 Mar 2020, 18:30
Display posts from previous: Sort by

Two alternative drugs are available to prevent blood clots from develo

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  





Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne